ライフサイエンスコーパス: knee osteoarthritis

1 erally administered for pain associated with knee osteoarthritis).

2 537 outpatients with symptomatic hip or knee osteoarthritis.

3 this treatment for patients with symptomatic knee osteoarthritis.

4 alent, incident symptomatic, and progressive knee osteoarthritis.

5 population and may accelerate development of knee osteoarthritis.

6 is a potentially modifiable risk factor for knee osteoarthritis.

7 y of individuals who have or are at risk for knee osteoarthritis.

8 l interventions among African-Americans with knee osteoarthritis.

9 ets for both prevention and intervention for knee osteoarthritis.

10 es were prevalent, incident, and progressive knee osteoarthritis.

11 d for quantifying changes in tibiofemoral in knee osteoarthritis.

12 viduals who have or who are at high risk for knee osteoarthritis.

13 waiting list control group for patients with knee osteoarthritis.

14 rt-term benefits of acupuncture for treating knee osteoarthritis.

15 ay possibly be more important in hip than in knee osteoarthritis.

16 uded in the treatment plan for patients with knee osteoarthritis.

17 nction in patients with existing symptomatic knee osteoarthritis.

18 a role in the management of unicompartmental knee osteoarthritis.

19 ortant in the development and progression of knee osteoarthritis.

20 d improve the symptoms of medial compartment knee osteoarthritis.

21 ave the potential to improve the symptoms of knee osteoarthritis.

22 the mechanisms for the production of pain in knee osteoarthritis.

23 function in patients with medial compartment knee osteoarthritis.

24 impact on the development and progression of knee osteoarthritis.

25 e obese 45-64-year-old women with unilateral knee osteoarthritis.

26 sical therapy treatment for individuals with knee osteoarthritis.

27 hening is a common goal in the management of knee osteoarthritis.

28 ely treat long-term pain and disability from knee osteoarthritis.

29 ve in improving balance in older adults with knee osteoarthritis.

30 ed 65 and older have radiographic changes of knee osteoarthritis.

31 ngly associated with the presence of pain in knee osteoarthritis.

32 er (aged 65-74 years), obese, or had hand or knee osteoarthritis.

33 d be prescribed as part of the treatment for knee osteoarthritis.

34 otwear is recommended for self-management of knee osteoarthritis.

35 eoarthritis; 9.5% of adults aged > 62 y have knee osteoarthritis.

36 r improving WOMAC knee pain in patients with knee osteoarthritis.

37 d physical function in patients with hip and knee osteoarthritis.

38 urse of physical therapy in the treatment of knee osteoarthritis.

39 lticenter study in patients with symptomatic knee osteoarthritis.

40 be a valid alternative treatment for chronic knee osteoarthritis.

41 ge insoles as a treatment for pain in medial knee osteoarthritis.

42 ol condition in patients with painful medial knee osteoarthritis.

43 h a degenerative medial meniscus tear and no knee osteoarthritis.

44 ing 45 blacks and 49 whites with symptomatic knee osteoarthritis.

45 l to the development of pain associated with knee osteoarthritis.

46 luronic acid, is widely used for symptomatic knee osteoarthritis.

47 rventions for community-dwelling adults with knee osteoarthritis.

48 is essential for evaluation of synovitis in knee osteoarthritis.

49 knee injuries increase the risk for incident knee osteoarthritis.

50 th inequality and malalignment with incident knee osteoarthritis.

51 progression of structural characteristics of knee osteoarthritis.

52 valence ratios for knee pain and symptomatic knee osteoarthritis.

53 eported pain were used to define symptomatic knee osteoarthritis.

54 associated with increased risk of developing knee osteoarthritis.

55 rior knee radiography to define radiographic knee osteoarthritis.

56 e difficulty in identifying risk factors for knee osteoarthritis.

57 njection or no intervention in patients with knee osteoarthritis?

58 Among patients with symptomatic knee osteoarthritis, 2 years of intra-articular triamcin

59 of the US population is affected with hip or knee osteoarthritis; 9.5% of adults aged > 62 y have kne

60 then tested in 62 individuals affected with knee osteoarthritis and 52 age matched controls and test

61 d trial with participants aged >50 y who had knee osteoarthritis and a body mass index [BMI (in kg/m(

62 buckling is common in persons with advanced knee osteoarthritis and after orthopedic procedures.

63 summarizes recent literature about obesity, knee osteoarthritis and joint pain.

64 Participants with symptomatic knee osteoarthritis and low 25-hydroxyvitamin D (12.5-60

65 Among patients with symptomatic knee osteoarthritis and low serum 25-hydroxyvitamin D le

66 ate quality-adjusted life-year losses due to knee osteoarthritis and obesity in comparison with the r

67 of quality-adjusted life-years lost owing to knee osteoarthritis and obesity seems to be substantial,

68 Policy Model, a computer simulation model of knee osteoarthritis and obesity, was used to estimate qu

69 ng risk factors for incident and progressive knee osteoarthritis and related knee pain to identify ta

70 s examined associations between radiographic knee osteoarthritis and serum levels of alpha-, delta-,

71 o estimate associations between radiographic knee osteoarthritis and tertiles of each tocopherol meas

72 The development of symptomatic knee osteoarthritis and the progression of joint space l

73 ents or interventions used for patients with knee osteoarthritis and their potential effects on pain

74 Associations between radiographic knee osteoarthritis and tocopherol isoforms are complex

75 Quality-adjusted life-years lost due to knee osteoarthritis and/or obesity represent 10% to 25%

76 onic pain conditions (chronic low back pain, knee osteoarthritis, and fibromyalgia).

77 risk factor for structural deterioration in knee osteoarthritis, and its relation to progression is

78 mass (in kilograms) and its change, painful knee osteoarthritis, and reduced quadriceps strength.

79 In 2000, body composition, x-ray-defined knee osteoarthritis, and self-reported knee pain informa

80 r for African-Americans than Caucasians with knee osteoarthritis, and some contributing factors have

81 sted prevalence of knee pain and symptomatic knee osteoarthritis approximately doubled in women and t

82 Obesity and knee osteoarthritis are among the most frequent chronic

83 While factors affecting the course of knee osteoarthritis are mostly unknown, lesions on bone

84 erol ratio had half the odds of radiographic knee osteoarthritis as those in the lowest tertile (adju

85 ) do not halt the progression of symptomatic knee osteoarthritis, as was previously suggested.

86 e accurate and cost-effective diagnostics of knee osteoarthritis at the primary healthcare level.

87 In this trial involving patients without knee osteoarthritis but with symptoms of a degenerative

88 plementation is associated with benefits for knee osteoarthritis, but current trial evidence is contr

89 rvention improved outcomes for patients with knee osteoarthritis, but it did not assess separate effe

90 es weight effectively in obese patients with knee osteoarthritis, but the role of LED in long-term we

91 The cumulative incidence of knee osteoarthritis by 65 years of age was 13.9% in part

92 The frequency of knee osteoarthritis continues to accelerate, likely beca

93 The number of new patients seen for knee osteoarthritis decreased by 6.7%, whereas the numbe

94 obesity is equivalent for the development of knee osteoarthritis; development appears to be strongly

95 ee osteoarthritis increased but radiographic knee osteoarthritis did not.

96 d-tear' condition, it is now recognized that knee osteoarthritis exists in the highly metabolic and i

97 nutritional supplements in the management of knee osteoarthritis has been changed by recent research.

98 s of the quadriceps as a clinical feature of knee osteoarthritis has been well recognized for some ti

99 Few new risk factors for progression of knee osteoarthritis have been identified in the past few

100 demiologic studies and systematic reviews of knee osteoarthritis have confirmed that being overweight

101 s observed in the prevalence of radiographic knee osteoarthritis in FOA Study participants.

102 of knee osteoarthritis [PROOF (PRevention of knee Osteoarthritis in Overweight Females) study].

103 actors common to the development of hand and knee osteoarthritis in this non-elderly female populatio

104 Adverse outcomes in knee osteoarthritis include pain, loss of function, and

105 Symptomatic knee osteoarthritis increased but radiographic knee oste

106 Knee osteoarthritis is a common and increasing cause of

107 Knee osteoarthritis is a major cause of pain and functio

108 ates, but this may vary according to gender; knee osteoarthritis is more common in Chinese than U.S.

109 nvolvement of the quadriceps muscle group in knee osteoarthritis is receiving increasing research int

110 Two hundred cases with radiographic knee osteoarthritis (Kellgren-Lawrence grades > or = 2)

111 ege of Rheumatology criteria for symptomatic knee osteoarthritis, Kellgren-Lawrence grades 2 or 3, we

112 een diabetes mellitus (diabetes) and risk of knee osteoarthritis (KOA) is confounded by high body mas

113 Knee osteoarthritis (KOA) is most common in the medial t

114 Knee osteoarthritis (KOA) is reported to have characteri

115 ce of osteoarthritis, prior studies indicate knee osteoarthritis may be more common in African-Americ

116 tween quadriceps strength and progression of knee osteoarthritis may differ according to these factor

117 Fifty-four older adults with hip or knee osteoarthritis (mean +/- SD age 75.3+/-7.1 years) p

118 n and women with advanced-stage, symptomatic knee osteoarthritis (OA) (n = 16).

119 to characterize dGEMRIC in the evaluation of knee osteoarthritis (OA) according to various radiograph

120 Biomechanical interventions for knee osteoarthritis (OA) aim to improve pain and retard

121 ip of knee malalignment to the occurrence of knee osteoarthritis (OA) among subjects without radiogra

122 Individuals with medial compartment knee osteoarthritis (OA) and genu varum use different mo

123 ted impact on patient function in studies of knee osteoarthritis (OA) and it is known that laxity inf

124 been documented as a feature of tibiofemoral knee osteoarthritis (OA) and may cause disease in this c

125 Knee osteoarthritis (OA) and pain are assumed to be barr

126 ssociations between radiographic features of knee osteoarthritis (OA) and pain have been demonstrated

127 herapists' use of exercise for patients with knee osteoarthritis (OA) and recent exercise recommendat

128 teoarthritis Initiative without radiographic knee osteoarthritis (OA) and without medial meniscal tea

129 Few risk factors for knee osteoarthritis (OA) are appreciated, and the discor

130 Fluctuations in pain in patients with knee osteoarthritis (OA) are common, but risk factors fo

131 py) is an emerging treatment for symptomatic knee osteoarthritis (OA) but its efficacy is uncertain.

132 women) of both radiographic and symptomatic knee osteoarthritis (OA) compared with that in the Frami

133 the effect of body weight on progression of knee osteoarthritis (OA) differs depending on the degree

134 Individuals with medial knee osteoarthritis (OA) experience knee laxity and inst

135 ystem to grade subchondral bone attrition in knee osteoarthritis (OA) has low interobserver reliabili

136 Patients with knee osteoarthritis (OA) have been shown to have somatos

137 raphic measures of the pathologic changes of knee osteoarthritis (OA) have shown modest associations

138 Previous studies of knee osteoarthritis (OA) have yielded variable estimates

139 recreational exercise on the development of knee osteoarthritis (OA) in a community-based cohort of

140 Knee osteoarthritis (OA) is a leading cause of disabilit

141 Knee osteoarthritis (OA) is believed to be highly preval

142 Progressive knee osteoarthritis (OA) is believed to result from loca

143 Knee osteoarthritis (OA) is highly prevalent and disabli

144 Knee osteoarthritis (OA) is highly prevalent, especially

145 tween knee pain and radiographic evidence of knee osteoarthritis (OA) is notoriously imperfect.

146 Symptomatic knee osteoarthritis (OA) is present in 1 in 8 patients a

147 e narrowing (JSN) over time in subjects with knee osteoarthritis (OA) is unknown.

148 Impairment of proprioception in knee osteoarthritis (OA) may contribute to, and/or resul

149 relative efficacy of available treatments of knee osteoarthritis (OA) must be determined for rational

150 the hypothesis that gait changes related to knee osteoarthritis (OA) of varied severity are associat

151 Subjects ages 50-79 years with knee osteoarthritis (OA) or at high risk of knee OA were

152 Chronic knee osteoarthritis (OA) pain patients (n = 56) underwen

153 with a 4-fold increase in the risk of medial knee osteoarthritis (OA) progression.

154 Preventive strategies against knee osteoarthritis (OA) require a knowledge of risk fac

155 es during walking of individuals with medial knee osteoarthritis (OA) to determine the influence of q

156 ers ages 55-85 years with moderate to severe knee osteoarthritis (OA) were recruited.

157 (age, 45-55 years) and with risk factors for knee osteoarthritis (OA) were studied by using knee radi

158 Knee osteoarthritis (OA), a common cause of chronic pain

159 Knee osteoarthritis (OA), a disorder of cartilage and pe

160 In a natural history study of symptomatic knee osteoarthritis (OA), both lateral view and fluorosc

161 e in studies of progression and treatment of knee osteoarthritis (OA), given the practical limitation

162 of the mechanisms and natural progression of knee osteoarthritis (OA), particularly in its early stag

163 In this cohort of subjects with knee osteoarthritis (OA), synovial fluid uric acid was s

164 In many patients with knee osteoarthritis (OA), the disease progresses, and th

165 t least a moderately severe degree of hip or knee osteoarthritis (OA), we examined the effects of rac

166 served functional performance in adults with knee osteoarthritis (OA).

167 ge loss contributes to pain in patients with knee osteoarthritis (OA).

168 hic arthropathy but has not been assessed in knee osteoarthritis (OA).

169 estigated taping effects in individuals with knee osteoarthritis (OA).

170 r who have or are at high risk of developing knee osteoarthritis (OA).

171 as reduced knee pain in patients with medial knee osteoarthritis (OA).

172 iceps weakness is a risk factor for incident knee osteoarthritis (OA).

173 ta in a natural history study of symptomatic knee osteoarthritis (OA).

174 dy is a natural history study of symptomatic knee osteoarthritis (OA).

175 on of joint space narrowing in patients with knee osteoarthritis (OA).

176 ty in older overweight and obese adults with knee osteoarthritis (OA).

177 by age, back pain, and radiographic hip and knee osteoarthritis (OA).

178 inal acupuncture treatments in patients with knee osteoarthritis (OA).

179 dergo knee replacement for the management of knee osteoarthritis (OA).

180 and human subjects, including patients with knee osteoarthritis (OA).

181 y of individuals who have or are at risk for knee osteoarthritis (OA).

182 loading and contribute to the progression of knee osteoarthritis (OA).

183 d Drug Administration-approved treatment for knee osteoarthritis (OA); however, its efficacy is contr

184 tics, disease burden (including radiographic knee osteoarthritis [OA]), self-reported disability, and

185 udies of subjects with high risk factors for knee osteoarthritis (obesity and anterior cruciate ligam

186 401 persons (mean age, 66.8 years) with knee osteoarthritis on radiography who were drawn from c

187 g appearances were observed in patients with knee osteoarthritis (on short-TE FSE, long-TE FSE, and S

188 udy that includes 4796 participants who have knee osteoarthritis or are at risk.

189 d as possible factors in the pathogenesis of knee osteoarthritis or as consequences of the disease.

190 tis (OR 1.36 [95% CI 1.00-1.84]; p < 0.049), knee osteoarthritis (OR 1.17 [95% CI 1.01-1.36]; p < 0.0

191 ity-adjusted life-years lost due to obesity, knee osteoarthritis, or both.

192 eficiency may be a risk factor for increased knee osteoarthritis pain in black Americans.

193 esponses to acupuncture treatment in chronic knee osteoarthritis pain patients (n = 45).

194 n D levels contribute to race differences in knee osteoarthritis pain.

195 flammatory activities suggest rethinking the knee osteoarthritis paradigm.

196 fied methodologic challenges to the study of knee osteoarthritis, particularly osteoarthritis progres

197 ferentiate phenotypes within a heterogeneous knee osteoarthritis population.

198 ception of malalignment, no risk factors for knee osteoarthritis progression have been identified.

199 omized controlled trial on the prevention of knee osteoarthritis [PROOF (PRevention of knee Osteoarth

200 Arthroscopic assessment of patients with knee osteoarthritis refractory to traditional therapy su

201 e of lateral wedges and lower pain in medial knee osteoarthritis, restriction of studies to those usi

202 ymptomatic patients with a meniscal tear and knee osteoarthritis results in better functional outcome

203 o determine the impact of early radiographic knee osteoarthritis (ROA) and ROA risk factors on femoro

204 Participants of the Framingham Knee Osteoarthritis Study were examined with a 1.5T MRI

205 Participants completed a questionnaire on knee osteoarthritis symptoms and underwent quantitative

206 riatic osteoarthritis, rheumatoid arthritis, knee osteoarthritis, systolic blood pressure, diastolic

207 lid alternative for the treatment of chronic knee osteoarthritis that is more logistically convenient

208 s ranged from 1.857 in nonobese persons with knee osteoarthritis to 3.501 for persons affected by bot

209 nfluence the responsiveness of patients with knee osteoarthritis to exercise and physical activity pr

210 rognostic biomarkers may be used in clinical knee osteoarthritis to identify subgroups in whom the di

211 l that captures the long-term progression of knee osteoarthritis to longitudinally assess pain-relate

212 uence the responsiveness of individuals with knee osteoarthritis to physical therapy.

213 omly assigned 1583 patients with symptomatic knee osteoarthritis to receive 1500 mg of glucosamine da

214 joint space narrowing (JSN) in patients with knee osteoarthritis treated with doxycycline.

215 rvational cohort data from the Vitamin D for Knee Osteoarthritis trial.

216 this research, we enrolled 40 patients with knee osteoarthritis undergoing total knee replacement in

217 Twelve patients with knee osteoarthritis underwent dGEMRIC and T1rho mapping

218 In patients with knee osteoarthritis, viscosupplementation is associated

219 Whereas once knee osteoarthritis was considered a 'wear-and-tear' con

220 Knee osteoarthritis was determined by Kellgren-Lawrence

221 wever a new measure for Japanese people with knee osteoarthritis was developed based on these constru

222 nity-dwelling older women (>/=70 years) with knee osteoarthritis was examined through self report, pr

223 Radiographic knee osteoarthritis was inversely associated with serum

224 ho had undergone primary, unilateral TKA for knee osteoarthritis were randomized to 1 of 2 interventi

225 men and women with radiographic evidence of knee osteoarthritis were randomly assigned to four 18-mo

226 tilage sGAG content in vivo in patients with knee osteoarthritis, whereas T1rho mapping does not appe

227 Patients with medial compartment knee osteoarthritis who have a visible varus thrust will

228 nrolled 100 patients with moderate-to-severe knee osteoarthritis who were eligible for unilateral tot

229 In patients with knee osteoarthritis who were eligible for unilateral tot

230 The conventional approach to treating knee osteoarthritis with analgesics and physical therapy

231 ular triamcinolone vs saline for symptomatic knee osteoarthritis with ultrasonic features of synoviti

232 aining, have been examined as treatments for knee osteoarthritis, with considerable variability in th